Please read the full information about warnings for Progynova Patches as detailed in your Patient Information Leaflet.
Taking an oestrogen-only HRT can increase the risk of excessive thickening of the womb lining, and endometrial cancer.
You should also talk to your doctor before attempting to stop Progynova patches.
You should contact a doctor if you experience unusual bleeding when on this product
You should go for regular breast screening and smear tests.
You should also check your breasts regularly and see your doctor if you notice changes such as dimpling of the skin, nipple changes or you can see or feel any lumps.
There is an increased risk of risk of developing blood clots with HRT tablets. You should stop taking Progynova patches and see a doctor if you notice signs of a blood clot.
HRT
Change the patch once a week.
Remove the protective liner from the patch, and place the patch (sticky side down), on a clean, dry area of the skin of your lower abdomen or buttocks.
It should not be applied to the breasts. The patches should be applied to a different site each time, especially ensuring that you do not apply to the same site twice in a row.
it can be reapplied or you can apply a new patch.
you should apply a patch for the remaining time period. If you forget to replace the patch for several days you may have breakthrough bleeding or spotting.
It is recommended to start on a lower dose and increase if necessary. Please seek further advice if you need support with this.
You have or have ever had breast cancer, or any form of cancer sensitive to oestrogens.
You have unexplained vaginal bleeding.
You have excessive thickening of the womb lining endometrial hyperplasia that is not being treated.
You have or have ever had a blood clot in the vein (such as DVT in the legs)
You have a blood clotting disorder.
You have or have ever had a heart attack, stroke or angina.
You have or have ever had liver disease.
You have a rare blood condition called porphyria.
Breakthrough bleeding at unexpected times
Breast pain or tenderness
Isooctyl acrylate, acrylamide, vinyl acetate copolymer, ethyl oleate, isopropyl myristate.
Glycerol monolaurate on a polyester release liner protected by a backing film.
The product still contains some active ingredient even after using, which carries potential of causing harm to the environment, so please discard carefully. Patches should be folded in half, sticky side together, and then disposed of.
Do not store above 30°C.